Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 65, Issue 5
Volume 65, Issue 5
1 September 2017
ISSN 1058-4838
EISSN 1537-6591

Volume 65, Issue 5, 1 September 2017

NEWS

Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages i–ii, https://doi.org/10.1093/cid/cix614

IN THE LITERATURE

Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages iii–iv, https://doi.org/10.1093/cid/cix678

ARTICLES AND COMMENTARIES

Arthur Y Kim
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 709–711, https://doi.org/10.1093/cid/cix501

Hepatitis B and C viruses are leading causes of liver disease. The United States should engage in a coordinated effort to eliminate viral hepatitis as a public health problem, which requires special attention to populations often seen by infectious disease clinicians.

Samuel M Jenness and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 712–718, https://doi.org/10.1093/cid/cix439

Human immunodeficiency virus preexposure prophylaxis (PrEP) could lead to reductions in bacterial sexually transmitted infections (STIs) among men who have sex with men if clinicians fully implement the Center for Disease Control and Prevention’s STI screening recommendations for PrEP users.

J Kevin Yin and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 719–728, https://doi.org/10.1093/cid/cix420

Our review of 30 studies found that influenza vaccination in children affords indirect protection to unimmunized persons of all ages in closely connected communities against laboratory-confirmed influenza, household members against illness compatible with influenza, and the elderly in wider communities against influenza-related mortality.

Barbara H Bardenheier and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 729–737, https://doi.org/10.1093/cid/cix442

We found a significantly lower risk of nontargeted infectious disease hospitalizations for children aged 16 through 24 months if the last type of vaccine they received prior to hospitalization was live-only compared with receipt of inactivated-only vaccines.

Samuel A Shelburne and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 738–745, https://doi.org/10.1093/cid/cix417

A whole-genome sequencing approach predicted phenotypic resistance to extended spectrum β-lactams for 4 leading causes of gram-negative bacteremia in neutropenic cancer patients at a level equal or superior to data generated in the clinical microbiology laboratory.

Gemma Moncunill and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 746–755, https://doi.org/10.1093/cid/cix429

Vaccine-specific helper T-cell type 1 and 2 responses are associated with increased and decreased odds of clinical malaria, respectively, in children and infants vaccinated with the malaria vaccine RTS,S/AS01E in a phase 3 trial in Africa.

Temitope A Folaranmi and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 756–763, https://doi.org/10.1093/cid/cix438

Although overall incidence is low, MSM are at increased risk of meningococcal disease compared to men not known to be MSM (non-MSM). HIV infection may play a key role in this increased risk.

Dicky L Tahapary and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 764–771, https://doi.org/10.1093/cid/cix416

Anthelmintic treatment reduces soil-transmitted helminth prevalence, total IgE, and eosinophil count, but has no effect on insulin resistance (IR) at the community level. In helminth-infected subjects, treatment significantly increases IR, highlighting the need for careful metabolic health monitoring with deworming programs.

Marva Seifert and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 772–778, https://doi.org/10.1093/cid/cix422

Among patients with suspected drug resistant tuberculosis, treatment with a later generation fluoroquinolone versus earlier generation or no fluoroquinolone significantly reduced mortality risk after adjusting for risk factors typically associated with poor outcomes.

Mark W Tenforde and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 779–786, https://doi.org/10.1093/cid/cix430

In a Botswana national meningitis survey, we observed a high 2013–2014 incidence of cryptococcal meningitis, particularly in men in their fourth or fifth decade, highlighting the need to target populations at high risk for advanced HIV and adopt differentiated care models.

Anna M M van Deursen and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 787–795, https://doi.org/10.1093/cid/cix419

In immunocompetent adults ≥65 years of age, 13-valent pneumococcal conjugate vaccine elicits significant increases in opsonophagocytic activity titers and IgG concentrations. Responses were sustained for 2 years postvaccination for subjects in each age stratum and comorbidity group.

M Eugenia Socías and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 796–802, https://doi.org/10.1093/cid/cix428

Between 1996 and 2015, prevalence of transmitted drug resistance (TDR) increased significantly among HIV-infected people who use drugs in Vancouver, mainly driven by increases in nonnucleoside reverse transcriptase inhibitor–related TDR, strongly supporting baseline resistance testing to guide antiretroviral selection.

Sarah S Jackson and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 803–810, https://doi.org/10.1093/cid/cix431

Centers for Disease Control and Prevention (CDC) surgical site infection (SSI) risk adjustment models do not adjust for patient comorbidities. We developed risk adjustment models using electronically-available comorbidities. The CDC should strongly consider adopting comorbidity-based risk adjustment.

Lucy A McNamara and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 811–818, https://doi.org/10.1093/cid/cix421

Analysis of US surveillance data demonstrates that both severe and clinically significant pertussis illnesses are less common among patients who have received age-appropriate vaccination for pertussis, demonstrating that the positive impact of pertussis vaccination extends beyond decreasing risk of disease.

Aida Sivro and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 819–826, https://doi.org/10.1093/cid/cix357

Significantly higher plasma levels of IL6, IL1β, and sIL1Rα were associated with increased risk, whereas plasma IFNβ levels were associated with a decreased risk of TB recurrence in TB Recurrence upon Treatment with HAART (TRuTH) cohort, based in Durban, South Africa.

Alexis J Pillsbury and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 827–832, https://doi.org/10.1093/cid/cix436

Existing evidence of a male herd protection impact from female human papillomavirus (HPV) vaccination comes from genital-wart and HPV infection studies. This is the first evidence from population-level immunity changes supporting an indirect effect in males temporally associated with female vaccination.

Candice Romero and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 833–839, https://doi.org/10.1093/cid/cix423

This study provides population-based incidence of norovirus from a tropical region. We noted substantially higher rates in children aged <2 years. Inclusion of vomiting syndromes resulted in higher capture of norovirus cases. Norovirus rate among controls was similar to rates reported globally.

REVIEW ARTICLE

Christine L Jonesteller and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 840–850, https://doi.org/10.1093/cid/cix369

The first decade of postlicensure data from 24 countries demonstrates that both globally recommended rotavirus vaccines are effective against severe rotavirus gastroenteritis across a range of mortality settings, supporting the World Health Organization recommendation for global use of rotavirus vaccines.

BRIEF REPORTS

Jack Bibby and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 851–854, https://doi.org/10.1093/cid/cix381
Vanessa N Raabe and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 855–859, https://doi.org/10.1093/cid/cix406
Sumanth Gandra and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 860–863, https://doi.org/10.1093/cid/cix413
Juhi Moon and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 864–866, https://doi.org/10.1093/cid/cix441

PHOTO QUIZ

Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Page 867, https://doi.org/10.1093/cid/cix303

ANSWER TO THE PHOTO QUIZ

Audrey Le and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 868–869, https://doi.org/10.1093/cid/cix308

CORRESPONDENCE

Alberto Corona and Dario Cattaneo
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Page 870, https://doi.org/10.1093/cid/cix388
Roger L Nation and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 870–871, https://doi.org/10.1093/cid/cix390
Andreas Ronit
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 872–873, https://doi.org/10.1093/cid/cix444
Maarten Cobussen and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Pages 873–874, https://doi.org/10.1093/cid/cix447
David S Y Ong and others
Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Page 874, https://doi.org/10.1093/cid/cix448

ERRATUM

Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Page 875, https://doi.org/10.1093/cid/cix235

COVER

Clinical Infectious Diseases, Volume 65, Issue 5, 1 September 2017, Page NP, https://doi.org/10.1093/cid/cix670
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close